Zobrazeno 1 - 10
of 56
pro vyhledávání: '"Sarah E Rutstein"'
Autor:
Sarah E Rutstein, Mitch Matoga, Jane S Chen, Esther Mathiya, Beatrice Ndalama, Naomi Nyirenda, Naomi Bonongwe, Shyreen Chithambo, Maganizo Chagomerana, Gerald Tegha, Mina C Hosseinipour, Michael E Herce, Edward Jere, Robert G Krysiak, Irving F Hoffman
Publikováno v:
JMIR Research Protocols, Vol 11, Iss 12, p e37395 (2022)
BackgroundPre-exposure prophylaxis (PrEP) reduces HIV acquisition risk by >90% and is a critical lever to reduce HIV incidence. Identifying individuals most likely to benefit from PrEP and retaining them on PrEP throughout HIV risk is critical to rea
Externí odkaz:
https://doaj.org/article/2dc72679c5044be6ae1ea767be09fa95
Autor:
Nora Ellen Rosenberg, Tapiwa A Tembo, Katherine R Simon, Katie Mollan, Sarah E Rutstein, Victor Mwapasa, Steven Masiano, Hanna E Huffstetler, Vivian Go, Maria H Kim
Publikováno v:
JMIR Formative Research, Vol 6, Iss 4, p e32899 (2022)
BackgroundDespite progress toward the Joint United Nations Programme on HIV/AIDS “95-95-95” targets (95% of HIV-positive persons tested, 95% of tested persons on treatment, and 95% of treated persons virally suppressed), a gap remains in achievin
Externí odkaz:
https://doaj.org/article/6829b145bad04425bd763ad836325816
Autor:
Sayaka Hino, Catherine Grodensky, Sarah E Rutstein, Carol Golin, M Kumi Smith, Lawrenson Christmas, William Miller, Sam Phiri, Cecilia Massa, Gift Kamanga, Audrey Pettifor
Publikováno v:
PLoS ONE, Vol 13, Iss 7, p e0201265 (2018)
Diagnosis of acute HIV infection (AHI) presents an opportunity to prevent HIV transmission during a highly infectious period. Disclosure is important during AHI as a means to facilitate safer sex practices and notify partners, particularly as those w
Externí odkaz:
https://doaj.org/article/fa2d4ebc7b01412db72685126f0c286b
Autor:
Sarah E Rutstein, Mina C Hosseinipour, Deborah Kamwendo, Alice Soko, Memory Mkandawire, Andrea K Biddle, William C Miller, Morris Weinberger, Stephanie B Wheeler, Abdoulaye Sarr, Sundeep Gupta, Frank Chimbwandira, Reuben Mwenda, Steve Kamiza, Irving Hoffman, Ronald Mataya
Publikováno v:
PLoS ONE, Vol 10, Iss 4, p e0124748 (2015)
To evaluate the feasibility and effectiveness of dried blood spots (DBS) use for viral load (VL) monitoring, describing patient outcomes and programmatic challenges that are relevant for DBS implementation in sub-Saharan Africa.We recruited adult ant
Externí odkaz:
https://doaj.org/article/7a0380bbdd174330bddfc45b14d69c87
Autor:
Nivedita L. Bhushan, Jane S. Chen, Courtney N. Maierhofer, Sarah E. Rutstein, Mitch Matoga, Edward Jere, Cecilia Massa, Beatrice Ndalama, Naomi Bonongwe, Esther Mathiya, Irving F. Hoffman, Kimberly A. Powers, Elli Schwartz, Sam Phiri, William C. Miller, Kathryn E. Lancaster
Publikováno v:
AIDS and Behavior.
Autor:
Jane S. Chen, Audrey E. Pettifor, Julie A.E. Nelson, Sam Phiri, Dana K. Pasquale, Wiza Kumwenda, Gift Kamanga, Mackenzie L. Cottrell, Craig Sykes, Angela D.M. Kashuba, Gerald Tegha, Robert Krysiak, Isaac Thengolose, Myron S. Cohen, Irving F. Hoffman, William C. Miller, Sarah E. Rutstein
Publikováno v:
J Acquir Immune Defic Syndr
BACKGROUND: Persons with acute HIV infection (AHI) are highly infectious and responsible for a disproportionate share of incident infections. Immediate antiretroviral therapy (ART) rapidly reduces blood viral loads (VL), but genital VLs after ART ini
Autor:
Sarah E Rutstein, Adams L Sibley, Trang Thu Do Nguyen, Ha Viet Tran, Le Minh Giang, Teerada Sripaipan, Minh Nguyen, Hanna E Huffstetler, William C Miller, Joseph J Eron, Cynthia L Gay, Vivian F Go
Publikováno v:
Open Forum Infectious Diseases. 9
Background Long-acting injectable antiretroviral therapy (LAI) is an exciting alternative to daily oral ART. Less frequent dosing afforded by LAI may be especially pertinent for persons who inject drugs (PWID), who experience more HIV-related mortali
Autor:
Sarah E. Rutstein, Mitch Matoga, Jane S. Chen, Esther Mathiya, Beatrice Ndalema, Naomi Nyirenda, Naomi Bonongwe, Shyreen Taoloka, Maganizo Chagomerana, Gerald Tegha, Mina C Hosseinipour, Michael E. Herce, Robert Krysiak, Irving F Hoffman
BACKGROUND Pre-exposure prophylaxis (PrEP), when taken as prescribed, reduces HIV acquisition risk by >90% and is a critical lever to reduce HIV incidence. Identifying persons most likely to benefit from PrEP and retaining them on PrEP throughout the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7b54723649c29ecf3289e1cffd65018d
https://doi.org/10.2196/preprints.37395
https://doi.org/10.2196/preprints.37395
Autor:
Jing Zhang, Chunyan Li, Junjie Xu, Zhili Hu, Sarah E Rutstein, Joseph D Tucker, Jason J Ong, Yongjun Jiang, Wenqing Geng, Sarah T Wright, Myron S Cohen, Hong Shang, Weiming Tang
Publikováno v:
Lancet HIV
BACKGROUND: Poor persistence to oral HIV pre-exposure prophylaxis (PrEP) diminishes clinical and public health benefits. This study synthesizes evidence regarding discontinuation, adherence, and re-initiation of PrEP among geographically diverse PrEP
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c551acea806f73beeb410417a54682d
https://europepmc.org/articles/PMC9124596/
https://europepmc.org/articles/PMC9124596/
Publikováno v:
The Lancet HIV. 7:e721-e730
When used appropriately, pre-exposure prophylaxis (PrEP) substantially reduces the risk of HIV acquisition. Early implementation outcomes often suggest poor PrEP adherence and persistence; however, this intervention is time-limited and the need for P